Late-life mood disorders

Clinics in Geriatric Medicine

Volumn 19, Issue 4, 2003, Pages 777-797

  Burke, William J ^a   Wengel, Steven P ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CARBAMAZEPINE; LITHIUM; MIRTAZAPINE; NEFAZODONE; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VENLAFAXINE;

AGING; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; DEMOGRAPHY; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; HUMAN; MOOD DISORDER; REVIEW; RISK FACTOR; SOCIAL PSYCHOLOGY;

EID: 0344844418     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0690(03)00041-7     Document Type: Review

References (75)

1. Reynolds CF, Chamey DS. Unmet needs in the diagnosis and treatment of mood disorders in later life. Biol Psychiatry 2002;52(3):145-7.
2. Meyers BS. Treatment and course of geriatric depression: Questions raised by an evolving clinical science. Am J Geriatr Psychiatry 2002;10(5):497-502.
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition. Washington, DC: American Psychiatric Association; 1994.
4. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1983;17:37-49.
5. Hendrie H, Callahan C, Levitt E, Hui S, Musick B, Austrom M, et al. Prevalence rates of major depressive disorders: the effects of varying the diagnostic criteria in an older primary care population. Am J Geriatr Psychiatry 1995;3:119-31.
6. Gallo J, Rabins P, Anthony C. Sadness in older persons: 13-year follow-up of a community sample in Baltimore, MD. Psychological Medicine 1999;29:341-50.
7. Berger AK, Fratiglioni L, Forsell Y, Winblad B, Backman L. The occurrence of depressive symptoms in the preclinical phase of AD: a population-based study. Neurology 1999;53(9): 1998-2002.
8. Burke WJ, Rubin EH, Morris JC, Berg L. Symptoms of "depression" in dementia of the Alzheimer type. Alzheimer Dis Assoc Disord 1988;2(4):356-62.
9. Burke WJ, Roccaforte WH, Wengel SP, McArthur-Miller D, Folks DG, Potter JF. Disagreement in the reporting of depressive symptoms between patients with dementia of the Alzheimer type and their collateral sources. Am J Geriatr Psychiatry 1998;6(4):308-19.
10. Alexopoulos G, Borson S, Cuthbert B, Devanand D, Mulsant B, Olin J, et al. Assessment of late life depression. Biol Psychiatry 2002;52:164-74.
11. Flint A. The complexity and challenge of non-major depression in late life. Am J Geriatr Psychiatry 2002;10(3):229-32.
12. Lavretsky H, Kumar A. Clinically significant non-major depression: old concepts, new insights. Am J Geriatr Psychiatry 2002;10(3):239-55.
13. Judd L, Akiskal H. The clinical and public health relevance of current research and subthreshold depressive symptoms to elderly patients. Am J Geriatr Psychiatry 2002;10(3):233-8.
14. Wells K, Steward S, Hays R, Bumam M, Rogers W, Daniels M, et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA 1989;262(7): 914-9.
15. Beekman A, Geerlings S, Deeg D, Smit J, Schoevers R, de Beurs E, et al. The natural history of late-life depression. Arch Gen Psychiatry 2002;59:605-11.
16. Thomas L, Mulsant BH, Solano FX, Black AM, Benasi S, Flynn T, et al. Response speed and rate of remission in primary and specialty care of elderly patients with depression. Am J Geriatr Psychiatry 2002;10:583-91.
17. Conwell Y, Pearson J. Theme issue: suicidal behaviors in older adults. Am J Geriatr Psychiatry 2002;10(4):359-61.
18. Conwell Y, Duberstein R, Caine E. Risk factors for suicide in later life. Bio Psych 2002;52:193-204.
19. Parkin D, Stengel E. Incidence of suicidal attempts in an urban community. Br Med J 1965;2:133-8.
20. Langley G, Bayatti N. Suicides Exe Vale Hospital, 1972-1981. Br J Psychiatry 1984;145:463-7.
21. Ganguli M, Dodge H, Mulsant B. Rates and predictors of mortality in an aging, rural, community-based cohort. Arch Gen Psychiatry 2002;59:1046-52.
22. Bula C, Wietlisbach V, Bumand B, Yersin B. Depressive symptoms as a predictor of 6-month outcomes and services utilization in elderly medical inpatients. Arch Intern Med 2001;161:2609-15.
23. Maier W, Lichtennann D, Minges J, Heun R, Hallmayer J, Klinger T. Unipolar depression in the aged: determinants of familial aggregation. J Affect Disorder 1991;23:53-61.
24. Krishnan RKR, Delong M, Kraemer H, Carney R, Spiegel D, Gordon C, et al. Comorbidity of depression with other medical diseases in the elderly. Biol Psychiatry 2002;52:559-88.
25. Robinson R, Kubos K, Starr L, Rao K, Price T. Mood disorders in stroke patients. Importance of location of lesion. Brain 1984;107:81-93.
26. Astrom M, Adolfsson R, Asplund K. Major depression in stroke patients: a 3-year longitudinal study. Stroke 1993;24:976-82.
27. Wade DT, Legh-Smith J, Hewer RA. Depressed mood after stroke: a community study of its frequency. Br J Psychiatry 1987;151:200-5.
28. Starkstein S, Robinson R, Price R. Comparison of cortical and subcortical lesions in the production of poststroke mood disorders. Brain 1987;110:1045-59.
29. Starkstein S, Bryer J, Berthier M, Cohen B, Price R, Robinson R. Depression after stroke: the importance of cerebral hemisphere asymmetries. J Neuropsychiatry Clin Neurosci 1991;3:276-85.
30. Jorge R, Robinson R, Arndt S, Forrester A, Geisler F, Starkstein S. Comparison between acute-and delayed-onset depression following traumatic brain injury. J Neuropsychiatry Clin Neurosci 1993;5:43-9.
31. Krishnan K, Jays J, Blazer D. MRI-defined vascular depression. Am J Psychiatry 1997;154:497-501.
32. Hickie I, Scott E, Mitchell P, Wilhelm K, Austin M, Bennett B. Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry 1999;37(3):151-60.
33. Figiel G, Krishnan K, Doraiswamy P, Rao V, Nemeroff K, Husain M, et al. Subcortical hyper-intensities on brain magnetic resonance imaging: a comparison between late-age onset and early-onset elderly depressed subjects. Neurobiol Aging 1991;12:245-7.
34. Thomas A, O'Brien J, Davis S, Ballard C, Barber R, Kalaria R, et al. Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. Arch Gen Psychiatry 2002;59:785-92.
35. Kalayam B, Alexopoulos G. Prefrontal dysfunction and treatment response in geriatric depression. Arch Gen Psychiatry 1999;56:713-8.
36. Alexopoulos G, Meyers B, Young R, Kalayam B, Kakuma T, Gabrielle M, et al. Executive dysfunction and long-term outcomes of geriatric depression. Arch Gen Psychiatry 2000;57:285-90.
37. Alexopoulos G, Kiosses D, Klimstra S, Kalayam B, Bruce M. Clinical presentation of the "depression-executive dysfunction syndrome" of late life. Am J Geriatr Psychiatry 2002;10(1): 98-106.
38. Steffens D, Helms M, Krishnan R, Burke G. Cerebrovascular disease and depression symptoms in the cardiovascular health study. Stroke 1999;30:2159-66.
39. O'Brien J, Ames D, Chiu E, Schweitzer K, Desmond P, Tress B. Severe deep white-matter lesions and outcome in elderly patients with major depressive disorder: follow up study. Br Med J 1998;317:982-4.
40. Hickie I, Scott E, Mitchell P, Welhem K, Austin M, Bennett B. Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry 1995;37:151-60.
41. Simpson S, Baldwin R, Jackson A, Bums A. Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroradiological findings in late-life depression. Psychol Med 1998;28(5):1015-26.
42. Salloway S, Boyle P, Correia S, Malloy P, Cahn-Weiner D, Schneider L. The relationship of MRI subcortical hyperintensities to treatment response in a trial of sertraline in geriatric depressed outpatients. Am J Geriatr Psychiatry 2002;10:107-11.
43. Miller M, Lenze E, Dew M, Whyte E, Weber E, Begley A, et al. Effect of cerebrovascular risk factors on depression treatment outcome in later life. Am J Geriatr Psychiatry 2002;10(5): 592-8.
44. Lyketsos C, Olin J. Depression in Alzheimer's disease: overview and treatment. Biol Psychiatry 2002;52:243-52.
45. Lyketsos C, Sheppard J, Steele C, Kopunek S, Steinberg M, Baker A, et al. A randomized, placebo-controlled, double-blind, clinical trial of sertraline in the treatment of depression complicating Alzheimer disease: initial results from the Depression in Alzheimer Disease Study (DIADS). Am J Psychiatry 2000;157:1686-9.
46. Nyth AL, Gottfries C. The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders: a Nordic multicentre study. Br J Psychiatry 1990;157:894-901.
47. Pollock BG, Mulsant BH, Rosen J, Sweet RA, Mazumdar S, et al. Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients. Am J Psychiatry 2002;159(3):460-5.
48. Cummings JL. Depression and Parkinson's disease: a review. Am J Psychiatry 1992;149(4): 443-54.
49. Menza M, Mark M. Parkinson's disease and depression: the relationship to disability and personality. J Neuropsychiatry Clin Neurosci 1994;6:165-9.
50. Glassman AH, Shapiro PA. Depression and the course of coronary artery disease. Am J Psychiatry 1998;155(1):4-11.
51. Bruce M. Psychosocial risk factors for depressive disorders in late life. Biol Psychiatry 2002;52:175-84.
52. Salzman C, Wong E, Wright B. Drug and ECT treatment of depression in the elderly, 1996-2001: a literature review. Biol Psychiatry 2002;52:265-84.
53. Gill D, Hatcher S. Antidepressants for depression in medical illness. Cochrane Review. In: The Cochrane Library. Issue 1. Oxford: Update Software; 2003.
54. Oxman T, Sengupta A. Treatment of minor depression. Am J Geriatr Psychiatry 2002;10(3): 256-64.
55. Reynolds C, Frank E, Perel J, Imber S, Comes C, Miller M, et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years. JAMA 1999;281(1):39-45.
56. Arean P, Cook B. Psychotherapy and combined psychotherapy/ pharmacotherapy for late life depression. Biol Psychiatry 2002;52:293-303.
57. Alexopoulos G, Katz I, Reynolds C, Carpenter D, Docherty J. Pharmacotherapy of depressive disorders in older patients. Postgrad Med Spec Rep 2001;October:1-88.
58. Unutzer J, Katon W, Williams J, Callahan C, Harpole L, Hunkeler E, et al. Improving primary care for depression in late life: the design of a multi-center randomized trail. Med Care 2001;39:785-99.
59. Cole M, Bellavance F, Mansour A. Prognosis of depression in elderly community and primary care populations: a systematic review and meta-analysis. Am J Psychiatry 1999;156(8):1182-9.
60. Unutzer J, Katon W, Callahan C, Williams J, Hunkeler E, Harpole L, et al. Collaborative care management of late-life depression in the primary care setting. JAMA 2002;288(22):2836-45.
61. Williams J, Barrett J, Oxman T, Frank E, Katon W, Sullivan M, et al. Treatment of dysthymia and minor depression in primary care: a randomized controlled trial in older adults. JAMA 2000;284(12):1519-26.
62. Hirschfeld RMA, Calabrese JR, Weissman MM, Reed M, Davies MA, Frye MA, et al. Screening for bipolar disorder in the community. J Clin Psychiatry 2003;64:53-9.
63. Yassa R, Nair V, Nastase C, Camille Y, Belzile L. Prevalence of bipolar disorder in a psycho-geriatric population. J Affect Disord 1988;14:197-201.
64. Shulman KI, Herrmann N. Bipolar disorder in old age. Can Fam Physician 1999;45:1229-37.
65. Shulman K, Post F. Bipolar affective disorder in old age. Br J Psychiatry 1980;136:26-32.
66. Stone K. Mania in the elderly. Br J Psychiatry 1989;155:220-4.
67. Snowden J. A retrospective case-note study of bipolar disorder in old age. Brit J Psychiat 1991;158:485-90.
68. Wylie ME, Mulsant BH, Pollock BG, Sweet RA, Zubenko GS, Begley AE, et al. Age at onset in geriatric bipolar disorder: effects on clinical presentation and treatment outcomes in an inpatient sample. Am J Geriatr Psychiatry 1999;7:77-83.
69. Dhingra U, Rabins PV. Mania in the elderly: a 5-7 year follow-up. J Am Geriatr Soc 1991;39:581-3.
70. Nath J, Sagar R. Late-onset bipolar disorder due to hyperthyroidism. Acta Psychiatr Scand 2001;104:72-5.
71. Fujikawa T, Yamawaki S, Touhouda Y. Silent cerebral infarctions in patients with late-onset mania. Stroke 1995;26:946-9.
72. Krishnan KRR. Biological risk factors in late life depression. Biol Psychiatry 2002;52:185-92.
73. Jacobsen SA, Pies RW, Greenblatt DJ. Mood stabilizers. In: Handbook of geriatric psychopharmacology. Washington, DC: American Psychiatric Publishing; 2002. p. 211-2.
74. Sanderson DR. Practical geriatrics: use of mood stabilizers by hospitalized geriatric patients with bipolar disorder. Psychiatr Serv 1998;49:1145-7.
75. Eastham JH, Jeste DV, Young RC. Assessment and treatment of bipolar disorder in the elderly. Drugs Aging 1998;12:205-24.